A Phase IIa Clinical Study of RG002C0106 Injection in Subjects With Primary IgA Nephropathy

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Peking University First Hospital, Beijing, Beijing Municipality